Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease?
- Alexander Tenenbaum
- , Valentina Boyko
- , Enrique Z. Fisman*
- , Ilan Goldenberg
- , Yehuda Adler
- , Micha S. Feinberg
- , Michael Motro
- , David Tanne
- , Joseph Shemesh
- , Ehud Schwammenthal
- , Solomon Behar
*Corresponding author for this work
- Sheba Medical Center at Tel Hashomer
- Tel Aviv University
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations